Shandong Sinobioway Biomedicine subsidiary, Unnamed TIAN AN, has obtained a drug operation license.
ST Wemeng (002581.SZ) announcement, the company's wholly-owned subsidiary Shandong Wemeng Tianan Pharmaceutical Co., Ltd. (referred to as "...
Shandong Sinobioway Biomedicine (002581.SZ) announced that its wholly-owned subsidiary Shandong Weiming TIAN AN Pharmaceutical Co., Ltd. (referred to as "Weiming TIAN AN") recently obtained a Drug Operation License issued by the Shandong Provincial Drug Administration. The permitted scope of operation includes traditional Chinese medicine, Chinese patent medicine, chemical drugs, biological products (except vaccines), and refrigerated and frozen drugs.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
